RPG LifeScience.
Drug Manufacturers - Specialty & Generic · RPGLIFE
Small CapHealthcareHigh Growth
Yugal Sikri
Managing Director · Transformational
Company DNA
Performance-Driven
About
RPG LifeScience. is a Small Cap company in the Healthcare sector, listed on NSE as RPGLIFE. With a market cap of ₹3K Cr and revenue of ₹648 Cr, it is currently in the High Growth phase. Known for its Performance-Driven culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Professional management under an experienced CEO focusing on high-growth pharma segments necessitates a clear, output-oriented KPI structure. Its strategic mandate: To scale in the competitive Indian pharma market, the company needs a leader who can prioritize portfolio expansion and R&D-led growth.
FAQ
What kind of company is RPG LifeScience.?
RPG LifeScience. is a Small Cap Healthcare company (RPGLIFE) in the High Growth phase with a market cap of ₹3K Cr. It is classified as Performance-Driven in culture.
What is RPG LifeScience.'s culture and work environment like?
RPG LifeScience. has a Performance-Driven culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Professional management under an experienced CEO focusing on high-growth pharma segments necessitates a clear, output-oriented KPI structure.
Who leads RPG LifeScience.?
RPG LifeScience. is led by Yugal Sikri (Managing Director), a Transformational leader with 42 years of experience.
What are RPG LifeScience.'s financials?
RPG LifeScience. reported revenue of ₹648 Cr in FY25 with a 5-year revenue CAGR of 14%. Operating margin: 21.7%. Market cap: ₹3K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleHigh Growth
Professional management under an experienced CEO focusing on high-growth pharma segments necessitates a clear, output-oriented KPI structure.
Mandate
To scale in the competitive Indian pharma market, the company needs a leader who can prioritize portfolio expansion and R&D-led growth.
To scale in the competitive Indian pharma market, the company needs a leader who can prioritize portfolio expansion and R&D-led growth.
Financials
Revenue FY25₹648 Cr
PAT FY25₹183 Cr
Rev CAGR 5Y14%
OPM21.7%
NPM28.3%
ROE34.5%
ROCE26.1%
P/E15.4
Fwd P/E65.8
P/B5.6
D/E—
Mkt Cap₹3K Cr
Promoter74.9%
Institutional7.5%
Similar Culture
Could You Lead RPG LifeScience.?
Take the Genome Benchmark →